Pfizer
This article was originally published in The Gray Sheet
Executive Summary
Plans to repurchase up to 20 mil. shares of common stock in the open market or in privately negotiated transactions "from time to time" over the next two years "depending upon market conditions." The firm has already completed a 10 mil. share repurchase program authorized last August and currently has approximately 323 mil. shares of common stock outstanding.